Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > evaluate Medmira and Chembio syphilis tests mar 2022
View:
Post by goldyhawk on Mar 12, 2022 9:21am

evaluate Medmira and Chembio syphilis tests mar 2022

Methods: One hundred serum samples with known syphilis serological status, based on treponemal and non-treponemal test results, were analysed in the laboratory with two POCTs by two independent operators in a blind fashion. Results were analysed to evaluate their ability to detect infectious syphilis. Results: The Reveal Rapid TP Antibody POCT showed an overall sensitivity of 95.0% and a specificity of 83.3%, while the DPP Syphilis Screen and Confirm POCT showed a sensitivity of 87.5% and a specificity of 98.3%. Both POCTs gave a sensitivity of 100% on active syphilis samples with Venereal Disease Research Laboratory (VDRL) titres of greater than 1:4, but their sensitivities decreased for samples with low VDRL titres. Both POCTs gave weakly or very weakly reactive results on 11.3%–25.0% of the treponemal antibody positive samples. Conclusion: This laboratory evaluation has shown promising results for both POCTs to detect infectious syphilis. Further evaluations in the field would be required to confirm this preliminary finding. This work is licensed under a Creative Commons Attribution 4.0 International License. Affiliations 1 Syphilis Diagnostic Unit, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB 2 Cadham Provincial Public Health Laboratory, Winnipeg, MB 3 Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB *Correspondence: raymond.tsang@phac-aspc.gc.ca Suggested citation: Tsang RSW, Shuel M, Hayden K, Van Caeseele P, Stein DR. Laboratory evaluation of two pointof-care test kits for the identification of infectious syphilis. Can Commun Dis Rep 2022;48(2/3):83–8. https://doi.org/10.14745/ccdr.v48i23a05 Keywords: infectious syphilis, point-of-care tests


https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2022-48/issue-2-3-february-march-2022/ccdrv48i23a05-eng.pdf
Comment by august202013 on Mar 12, 2022 1:49pm
WHAT IS THE POINT ! WHEN SARS CAME AND GONE MIR WAS AMONGST FIRST THEN WHEN COVID19 CAME MIR AGAIN FIRST TO COME WITH COVID19 & SARS TEST KIT WAS WAS TOLD TO TEST ONLY FOR COVID19 AND ALMOST GONE WELL RIGHT GUESS ABBOTT GOT THEIR APPROVAL AND HC PO AND NOW GIVEN FOR FREE TO CANADIAN AGED 60 YEARS AND UP AND KIDS AT SCHOOL. WHY HC BOUGHT AND GAVE FOR FREE. GOLDYHAWK YOU ARE CORRECT MIR MIGHT BE ...more  
Comment by goldyhawk on Mar 12, 2022 3:13pm
august202013 (27) User Actions   March 03, 2022 - 11:32 AM 98 Reads Post# 34479287 CONTINUE TO ACCUMULATE AND AT NEXT AGM DEMAND FOR A BOARD ME Let's continue to accumulate and request for a BOARD MEMBER. Perhaps by then there will be some changes in direction. When there is any new WAVE Perhaps long-term Medmira individual shareholders ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities